{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "IFN-I", "Illness severity", "Immune-phenotype", "Signaling pathway"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35842705", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "19"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "16"}], "Language": ["eng"], "ELocationID": ["106", "10.1186/s12964-022-00903-6"], "Journal": {"ISSN": "1478-811X", "JournalIssue": {"Volume": "20", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "16"}}, "Title": "Cell communication and signaling : CCS", "ISOAbbreviation": "Cell Commun Signal"}, "ArticleTitle": "A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients.", "Pagination": {"StartPage": "106", "MedlinePgn": "106"}, "Abstract": {"AbstractText": ["The COVID-19 pandemic has become the world's main life-threatening challenge in the third decade of the twenty-first century. Numerous studies have been conducted on SARS-CoV2 virus structure and pathogenesis to find reliable treatments and vaccines. The present study aimed to evaluate the immune-phenotype and IFN-I signaling pathways of COVID-19 patients with mild and severe conditions.", "A total of 100 COVID-19 patients (50 with mild and 50 with severe conditions) were enrolled in this study. The frequency of CD4\u2009+\u2009T, CD8\u2009+\u2009T, Th17, Treg, and B lymphocytes beside NK cells was evaluated using flow cytometry. IFN-I downstream signaling molecules, including JAK-1, TYK-2, STAT-1, and STAT-2, and Interferon regulatory factors (IRF) 3 and 7 expressions at RNA and protein status were investigated using real-time PCR and western blotting techniques, respectively. Immune levels of cytokines (e.g., IL-1\u03b2, IL-6, IL-17, TNF-\u03b1, IL-2R, IL-10, IFN-\u03b1, and IFN-\u03b2) and the existence of anti-IFN-\u03b1 autoantibodies were evaluated via enzyme-linked immunosorbent assay (ELISA).", "Immune-phenotyping results showed a significant decrease in the absolute count of NK cells, CD4\u2009+\u2009T, CD8\u2009+\u2009T, and B lymphocytes in COVID-19 patients. The frequency of Th17 and Treg cells showed a remarkable increase and decrease, respectively. All signaling molecules of the IFN-I downstream pathway and IRFs (i.e., JAK-1, TYK-2, STAT-1, STAT-2, IRF-3, and IRF-7) showed very reduced expression levels in COVID-19 patients with the severe condition compared to healthy individuals at both RNA and protein levels. Of 50 patients with severe conditions, 14 had anti-IFN-\u03b1 autoantibodies in sera. Meanwhile, this result was 2 and 0 for patients with mild symptoms and healthy controls, respectively.", "Our results indicate a positive association of the existence of anti-IFN-\u03b1 autoantibodies and immune cells dysregulation with the severity of illness in COVID-19 patients. However, comprehensive studies are necessary to find out more about this context. Video abstract."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Soltani-Zangbar", "ForeName": "Mohammad Sadegh", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Parhizkar", "ForeName": "Forough", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pirogov Russian National Research Medical University, Moscow, Russia."}], "LastName": "Ghaedi", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiology, Medical Faculty, Urmia University of Medical Sciences, Urmia, Iran."}], "LastName": "Tarbiat", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Motavalli", "ForeName": "Roza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Alizadegan", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Aghebati-Maleki", "ForeName": "Leili", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Rostamzadeh", "ForeName": "Davoud", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Yousefzadeh", "ForeName": "Yousef", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Jadideslam", "ForeName": "Golamreza", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Farid", "ForeName": "Sima Shahmohammadi", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Roshangar", "ForeName": "Leila", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Mahmoodpoor", "ForeName": "Ata", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Allergy and Clinical Immunology, Pediatric Hospital, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Heris", "ForeName": "Javad Ahmadian", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology and Mycology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran."}], "LastName": "Miahipour", "ForeName": "Abolfazl", "Initials": "A"}, {"Identifier": ["0000-0003-0099-6728"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. yousefime@tbzmed.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. yousefime@tbzmed.ac.ir."}], "LastName": "Yousefi", "ForeName": "Mehdi", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Video-Audio Media", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Commun Signal", "NlmUniqueID": "101170464", "ISSNLinking": "1478-811X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Autoantibodies"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Viral"}, {"RegistryNumber": "9008-11-1", "NameOfSubstance": "Interferons"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Autoantibodies"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Interferons"}, {"QualifierName": [], "DescriptorName": "Killer Cells, Natural"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "RNA, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "Authors declare no conflict of interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, Casetti R, Giancola ML, Bevilacqua N, Maeurer M. An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019. Clin Infect Dis. 2020;71:2272\u20132275. doi: 10.1093/cid/ciaa577.", "ArticleIdList": ["10.1093/cid/ciaa577", "PMC7239202", "32407466"]}, {"Citation": "Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, Chen L, Li J, Wang X, Wang F. The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing. MedRxiv. 2020;199:1517."}, {"Citation": "Soltani-Zangbar MS, Aghebati-Maleki L, Hajivalili M, Haji-Fatahaliha M, Motavalli R, Mahmoodpoor A, Kafil HS, Farhang S, Pourakbari R, Jadidi-Niaragh F. Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation. Gene Rep. 2021;23:101140. doi: 10.1016/j.genrep.2021.101140.", "ArticleIdList": ["10.1016/j.genrep.2021.101140", "PMC8041740", "33869895"]}, {"Citation": "Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X. Coronavirus infections and immune responses. J Med Virol. 2020;92:424\u2013432. doi: 10.1002/jmv.25685.", "ArticleIdList": ["10.1002/jmv.25685", "PMC7166547", "31981224"]}, {"Citation": "Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1\u20139.", "ArticleIdList": ["32105090"]}, {"Citation": "Motavalli R, Abdelbasset WK, Rahman HS, Achmad MH, Sergeevna NK, Zekiy AO, Adili A, Khiavi FM, Marofi F, Yousefi M. The lethal internal face of the coronaviruses: kidney tropism of the SARS, MERS, and COVID 19 viruses. IUBMB Life. 2021;73:1005\u20131015. doi: 10.1002/iub.2516.", "ArticleIdList": ["10.1002/iub.2516", "PMC8426673", "34118117"]}, {"Citation": "Li CKF, Wu H, Yan H, Ma S, Wang L, Zhang M, Tang X, Temperton NJ, Weiss RA, Brenchley JM, Douek DC. T cell responses to whole SARS coronavirus in humans. J Immunol. 2008;181:5490\u20135500. doi: 10.4049/jimmunol.181.8.5490.", "ArticleIdList": ["10.4049/jimmunol.181.8.5490", "PMC2683413", "18832706"]}, {"Citation": "Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev. 2006;211:81\u201392. doi: 10.1111/j.0105-2896.2006.00382.x.", "ArticleIdList": ["10.1111/j.0105-2896.2006.00382.x", "16824119"]}, {"Citation": "Etemadi J, Bordbar S, Soltani-Zangbar MS, Hajivalili M, Aghebati-Maleki L, Motavalli R, Mahmoodpoor A, Shahmohammadi-Farid S, Abedi Azar S, Niknafs B. Prevalence of SARS-CoV-2 specific antibodies in asymptomatic hemodialysis patients. Immunol Investig. 2021;2021:1\u201312.", "ArticleIdList": ["33752550"]}, {"Citation": "Mullen AC, Hutchins AS, High FA, Lee HW, Sykes KJ, Chodosh LA, Reiner SL. Hlx is induced by and genetically interacts with T-bet to promote heritable TH 1 gene induction. Nat Immunol. 2002;3:652\u2013658. doi: 10.1038/ni807.", "ArticleIdList": ["10.1038/ni807", "12055627"]}, {"Citation": "Mahmoodpoor A, Hosseini M, Soltani-Zangbar S, Sanaie S, Aghebati-Maleki L, Saghaleini SH, Ostadi Z, Hajivalili M, Bayatmakoo Z, Haji-Fatahaliha M. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression. Mol Immunol. 2021;138:121\u2013127. doi: 10.1016/j.molimm.2021.06.001.", "ArticleIdList": ["10.1016/j.molimm.2021.06.001", "PMC8343383", "34392110"]}, {"Citation": "Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med. 2008;26:711\u2013715. doi: 10.1016/j.ajem.2007.10.031.", "ArticleIdList": ["10.1016/j.ajem.2007.10.031", "18606328"]}, {"Citation": "Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334\u20131349. doi: 10.1056/NEJM200005043421806.", "ArticleIdList": ["10.1056/NEJM200005043421806", "10793167"]}, {"Citation": "Park A, Iwasaki A. Type I and type III interferons\u2013induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe. 2020;27:870\u2013878. doi: 10.1016/j.chom.2020.05.008.", "ArticleIdList": ["10.1016/j.chom.2020.05.008", "PMC7255347", "32464097"]}, {"Citation": "Stockinger S, Decker T. Stats and infection. In Madame Curie Bioscience Database [Internet]. Landes Bioscience; 2013."}, {"Citation": "Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV. The role of interleukin 6 during viral infections. Front Microbiol. 2019;10:1057. doi: 10.3389/fmicb.2019.01057.", "ArticleIdList": ["10.3389/fmicb.2019.01057", "PMC6524401", "31134045"]}, {"Citation": "Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, P\u00e9r\u00e9 H, Charbit B, Bondet V, Chenevier-Gobeaux C. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718\u2013724. doi: 10.1126/science.abc6027.", "ArticleIdList": ["10.1126/science.abc6027", "PMC7402632", "32661059"]}, {"Citation": "Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles\u2019 heel of current strategies to control Covid-19. New Engl J Med. 2020;382:2158\u201360. doi: 10.1056/NEJMe2009758.", "ArticleIdList": ["10.1056/NEJMe2009758", "PMC7200054", "32329972"]}, {"Citation": "Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M\u00f8ller R, Jordan TX, Oishi K, Panis M, Sachs D, Wang TT. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036\u201345. doi: 10.1016/j.cell.2020.04.026.", "ArticleIdList": ["10.1016/j.cell.2020.04.026", "PMC7227586", "32416070"]}, {"Citation": "Yang D, Chu H, Hou Y, Chai Y, Shuai H. Lee AC-Y, Zhang X, Wang Y, Hu B, Huang X: Attenuated interferon and proinflammatory response in SARS-CoV-2\u2013infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J Infect Dis. 2020;222:734\u2013745. doi: 10.1093/infdis/jiaa356.", "ArticleIdList": ["10.1093/infdis/jiaa356", "PMC7337793", "32563187"]}, {"Citation": "Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, B\u00e9ziat V, Manry J. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.", "ArticleIdList": ["10.1126/science.abd4585", "PMC7857397", "32972996"]}, {"Citation": "Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, Bucci E, Piacentini M, Ippolito G, Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451\u20134. doi: 10.1038/s41418-020-0530-3.", "ArticleIdList": ["10.1038/s41418-020-0530-3", "PMC7091918", "32205856"]}, {"Citation": "Matsuyama T, Kubli SP, Yoshinaga SK, Pfeffer K, Mak TW. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 2020;27:3209\u20133225. doi: 10.1038/s41418-020-00633-7.", "ArticleIdList": ["10.1038/s41418-020-00633-7", "PMC7545020", "33037393"]}, {"Citation": "Kerdiles YM, Sellin CI, Druelle J, Horvat B. Immunosuppression caused by measles virus: role of viral proteins. Rev Med Virol. 2006;16:49\u201363. doi: 10.1002/rmv.486.", "ArticleIdList": ["10.1002/rmv.486", "16237742"]}, {"Citation": "Qin CZ, Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020.", "ArticleIdList": ["PMC7108125", "32161940"]}, {"Citation": "Liu R, Wang Y, Li J, Han H, Xia Z, Liu F, Wu K, Yang L, Liu X, Zhu C. Decreased T cell populations contribute to the increased severity of COVID-19. Clin Chim Acta. 2020;508:110\u2013114. doi: 10.1016/j.cca.2020.05.019.", "ArticleIdList": ["10.1016/j.cca.2020.05.019", "PMC7219428", "32405080"]}, {"Citation": "He R, Lu Z, Zhang L, Fan T, Xiong R, Shen X, Feng H, Meng H, Lin W, Jiang W. The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol. 2020;127:104361. doi: 10.1016/j.jcv.2020.104361.", "ArticleIdList": ["10.1016/j.jcv.2020.104361", "PMC7152870", "32344320"]}, {"Citation": "Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.", "ArticleIdList": ["10.1016/j.ebiom.2020.102763", "PMC7165294", "32361250"]}, {"Citation": "Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci. 2021;276:119437. doi: 10.1016/j.lfs.2021.119437.", "ArticleIdList": ["10.1016/j.lfs.2021.119437", "PMC8005319", "33789145"]}, {"Citation": "Tahmasebi S, El-Esawi MA, Mahmoud ZH, Timoshin A, Valizadeh H, Roshangar L, Varshoch M, Vaez A, Aslani S, Navashenaq JG. Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. J Cell Physiol. 2021;236:5325\u20135338. doi: 10.1002/jcp.30233.", "ArticleIdList": ["10.1002/jcp.30233", "33372280"]}, {"Citation": "Zheng H-Y, Zhang M, Yang C-X, Zhang N, Wang X-C, Yang X-P, Dong X-Q, Zheng Y-T. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541\u2013543. doi: 10.1038/s41423-020-0401-3.", "ArticleIdList": ["10.1038/s41423-020-0401-3", "PMC7091621", "32203186"]}, {"Citation": "Liu S-Y, Sanchez DJ, Aliyari R, Lu S, Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci. 2012;109:4239\u20134244. doi: 10.1073/pnas.1114981109.", "ArticleIdList": ["10.1073/pnas.1114981109", "PMC3306696", "22371602"]}, {"Citation": "Heinonen S, Velazquez VM, Ye F, Mertz S, Acero-Bedoya S, Smith B, Bunsow E, Garcia-Mauri\u00f1o C, Oliva S, Cohen DM. Immune profiles provide insights into respiratory syncytial virus disease severity in young children. Sci Transl Med. 2020;12:eaaw0268. doi: 10.1126/scitranslmed.aaw0268.", "ArticleIdList": ["10.1126/scitranslmed.aaw0268", "32321862"]}, {"Citation": "Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD. SARS-CoV-2 is sensitive to type I interferon pretreatment. BioRxiv. 2020 doi: 10.1101/2020.03.07.982264.", "ArticleIdList": ["10.1101/2020.03.07.982264", "PMC7654262", "32938761"]}, {"Citation": "Lokugamage KG, Hage A, de Vries M, Valero-Jimenez AM, Schindewolf C, Dittmann M, Rajsbaum R, Menachery VD. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. J Virol. 2020;94:e01410\u201301420. doi: 10.1128/JVI.01410-20.", "ArticleIdList": ["10.1128/JVI.01410-20", "PMC7654262", "32938761"]}, {"Citation": "Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol. 2007;81:9812\u20139824. doi: 10.1128/JVI.01012-07.", "ArticleIdList": ["10.1128/JVI.01012-07", "PMC2045396", "17596301"]}, {"Citation": "Frieman MB, Chen J, Morrison TE, Whitmore A, Funkhouser W, Ward JM, Lamirande EW, Roberts A, Heise M, Subbarao K. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog. 2010;6:e1000849. doi: 10.1371/journal.ppat.1000849.", "ArticleIdList": ["10.1371/journal.ppat.1000849", "PMC2851658", "20386712"]}, {"Citation": "Liu Y, Zhang C, Huang F, Yang Y, Wang F, Yuan J, Zhang Z, Qin Y, Li X, Zhao D. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Natl Sci Rev. 2020;7:1003\u20131011. doi: 10.1093/nsr/nwaa037.", "ArticleIdList": ["10.1093/nsr/nwaa037", "PMC7107806", "34676126"]}, {"Citation": "Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123\u20131130. doi: 10.1080/22221751.2020.1770129.", "ArticleIdList": ["10.1080/22221751.2020.1770129", "PMC7473317", "32475230"]}, {"Citation": "Xu Q, Katakura Y, Yamashita M, Fang S, Tamura T, Matsumoto SE, Aiba Y, Teruya K, Osada K, Nishikawa R, Shirahata S. IL-10 augments antibody production in in vitro immunized lymphocytes by inducing a Th2-type response and B cell maturation. Biosci Biotechnol Biochem. 2004;68:2279\u201384. doi: 10.1271/bbb.68.2279.", "ArticleIdList": ["10.1271/bbb.68.2279", "15564665"]}, {"Citation": "Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20131034. doi: 10.1016/S0140-6736(20)30628-0.", "ArticleIdList": ["10.1016/S0140-6736(20)30628-0", "PMC7270045", "32192578"]}, {"Citation": "Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ, Harhay MO, Legrand M. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233\u201344. doi: 10.1016/S2213-2600(20)30404-5.", "ArticleIdList": ["10.1016/S2213-2600(20)30404-5", "PMC7567529", "33075298"]}, {"Citation": "Gupta S, Tatouli IP, Rosen LB, Hasni S, Alevizos I, Manna ZG, Rivera J, Jiang C, Siegel RM, Holland SM. Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases. Arthrit Rheumatol. 2016;68:1677\u20131687. doi: 10.1002/art.39607.", "ArticleIdList": ["10.1002/art.39607", "PMC5391258", "26815287"]}, {"Citation": "Aydinoglu-Candan \u00d6, Araz-Er\u015fan B, Gul A, Badur S, Tugal-Tutkun I. Anti-interferon alpha antibodies and autoantibodies in patients with Beh\u00e7et\u2019s disease uveitis treated with recombinant human interferon alpha-2a. Graefes Arch Clin Exp Ophthalmol. 2015;253:457\u2013465. doi: 10.1007/s00417-014-2856-3.", "ArticleIdList": ["10.1007/s00417-014-2856-3", "25500983"]}, {"Citation": "Goncalves D, Mezidi M, Bastard P, Perret M, Saker K, Fabien N, Pescarmona R, Lombard C, Walzer T, Casanova JL, Belot A. Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients. Clin Transl Immunol. 2021;10(8):e1327. doi: 10.1002/cti2.1327.", "ArticleIdList": ["10.1002/cti2.1327", "PMC8370568", "34429968"]}, {"Citation": "Ter\u00e1n-Cabanillas E, Hern\u00e1ndez J. Role of leptin and SOCS3 in inhibiting the type I interferon response during obesity. Inflammation. 2017;40:58\u201367. doi: 10.1007/s10753-016-0452-x.", "ArticleIdList": ["10.1007/s10753-016-0452-x", "27704310"]}, {"Citation": "Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol. 2009;27:165\u2013197. doi: 10.1146/annurev.immunol.021908.132620.", "ArticleIdList": ["10.1146/annurev.immunol.021908.132620", "PMC2734407", "19302038"]}, {"Citation": "Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, Lafaille FG, Trouillet C, Schmolke M, Albrecht RA. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 2015;348:448\u2013453. doi: 10.1126/science.aaa1578.", "ArticleIdList": ["10.1126/science.aaa1578", "PMC4431581", "25814066"]}, {"Citation": "Clohisey S, Baillie JK. Host susceptibility to severe influenza A virus infection. Crit Care. 2019;23:1\u201310. doi: 10.1186/s13054-019-2566-7.", "ArticleIdList": ["10.1186/s13054-019-2566-7", "PMC6729070", "31488196"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "11"}, {"Year": "2022", "Month": "5", "Day": "22"}, {"Year": "2022", "Month": "7", "Day": "16", "Hour": "23", "Minute": "31"}, {"Year": "2022", "Month": "7", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["35842705", "PMC9287826", "10.1186/s12964-022-00903-6", "10.1186/s12964-022-00903-6"]}}], "PubmedBookArticle": []}